Illustration of a clinic building (not a photo of Duke Clinic DUHS)
Illustration

Harry Erba, MD

Medical Oncology in Durham, NC

  • Enrolled in Medicare
  • Accepts Medicare assignment
  • 38 years since graduation
  • Public record — not managed by the clinician

About Dr. Harry Erba

Dr. Harry Erba is a physician specializing in medical oncology practicing in Durham, NC, a graduate of Stanford University School of Medicine (1988). Records list 3 practice addresses. Affiliated with Duke Regional Hospital, Duke University Hospital. Treated 134 Medicare patients in 2024.

Provider details

SpecialtyMedical OncologyOther medical oncology doctors in Durham
Also practicesHematology
CredentialsMD
EducationStanford University School of Medicine, 1988CMS Doctors and Clinicians
GenderMale
NPI number1508942566National Provider Identifier (CMS NPPES), issued October 2006
MedicareEnrolled in Medicare; accepts Medicare assignment (the Medicare-approved amount as full payment)CMS Doctors and Clinicians

Dr. Harry Erba's specialties and state licenses

  • Medical Oncology Primary
    License: MI 4301068402
  • Hematology
    License: MI 4301068402
  • Internal Medicine
    License: MI 4301068402

As reported by the clinician to the NPPES registry. Confirm a license and any disciplinary history with the state medical or licensing board.

Where Dr. Harry Erba practices

Addresses from CMS Doctors and Clinicians (Medicare enrollment). Call before visiting: a clinician may not see patients at every listed address.

Hospital affiliations of Dr. Harry Erba

  • Duke Regional HospitalHospital · Durham, NC
  • Duke University HospitalHospital · Durham, NC

CMS Facility Affiliation data: facilities where the clinician bills Medicare.

Dr. Harry Erba's Medicare patients and services (2024)

134Medicare patients
821services billed
74average patient age
46%women

Most frequent services

ServiceTimesAvg. Medicare allowed
Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes251$73.49
Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's246$15.46
Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more235$90.95
Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more22$130.33
New patient office or other outpatient visit with a high level of medical decision making, if using time, 60 minutes or more15$169.27
Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes14$161.03
Hospital discharge day management, 30 minutes or less13$75.51

Common conditions among these patients

  • High blood pressure72%
  • High cholesterol70%
  • Arthritis51%
  • Anxiety disorders31%
  • Ischemic heart disease31%
  • Chronic kidney disease28%

Medicare Part B fee-for-service claims only (CMS Medicare Physician & Other Practitioners, 2024). Patients with private insurance or Medicare Advantage are not counted; small counts are suppressed by CMS. This describes the patients, not the quality of care.

Payments from drug and device companies to Dr. Harry Erba (2025)

$187,022.43 in 138 general payments reported in 2025.

TypePaymentsAmount
Compensation for services other than consulting27$81,750.50
Consulting fees17$53,447.75
Speaker or faculty fees for medical education programs5$24,140
Travel and lodging62$21,350.11
Food and beverage26$3,594.07
Honoraria1$2,740

Paying companies: Incyte Corporation ($78,041.95), Daiichi Sankyo Inc. ($38,680.14), Servier Pharmaceuticals LLC ($34,129.20), Syndax Pharmaceuticals, Inc. ($20,768.82), Taiho Oncology, Inc. ($6,471.79), Sumitomo Pharma America, Inc. ($6,020).

Reported by companies under the federal Open Payments program (CMS, program year 2025). A payment, such as a meal at an educational event, does not mean wrongdoing; clinicians can dispute records with CMS.

Also at Duke Clinic DUHS

Questions about Dr. Harry Erba

What kind of clinician is Dr. Harry Erba?

Dr. Harry Erba is listed as a physician specializing in medical oncology, also practicing hematology.

Where does Dr. Harry Erba practice?

Duke Clinic DUHS at 40 Duke Medicine Cir, Durham, NC 27710, and 2 other addresses in the records.

What is the office phone number for Dr. Harry Erba?

The listed office number is (919) 684-8111. Call to confirm availability and whether new patients are accepted.

What is the NPI number of Dr. Harry Erba?

The National Provider Identifier is 1508942566.

Does Dr. Harry Erba accept Medicare?

Yes. CMS lists this clinician as accepting Medicare assignment. Confirm your plan with the office.

Which hospitals is Dr. Harry Erba affiliated with?

Duke Regional Hospital, Duke University Hospital.

Where did Dr. Harry Erba go to medical school?

Stanford University School of Medicine, graduating in 1988.

Where this information comes from

CMS Doctors and CliniciansName, specialty, education, Medicare enrollment and practice addresses.Centers for Medicare & Medicaid Services, national downloadable file (2026)
NPPES NPI registryNPI, specialties (taxonomy) and state licenses.CMS National Plan and Provider Enumeration System; record updated 2012-03-01
Facility affiliationsHospitals and other facilities.CMS Doctors and Clinicians facility affiliation file; names from CMS Provider of Services
Medicare utilizationPatients, services and conditions.CMS Medicare Physician & Other Practitioners, 2024
Open PaymentsPayments from drug and device companies.CMS Open Payments, program year 2025

Information is public record and may lag behind changes. Clinicians update it through NPPES and Medicare PECOS. See something wrong? Tell us.

Need an appointment?

Call Duke Clinic DUHS at (919) 684-8111 or visit the clinic page to check availability.

Call now
0 clinics selected Compare